Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Fresenius Kabi USA, LLC | Wilson, NC, United States | Makes it and tests it | Problems found, fixed voluntarilyFeb 13, 2026 · 5 inspections |
Recalls
- Oct 27, 2017 · Class I · Fresenius Kabi USA, LLC
Labeling: Label MIX-UP. Blister Packages, Labeled as Midazolam injection, USP, 2 mg / 2 ml, Containing Syringes of Ondansetron Injection, USP, 4 mg / 2 mL
Lots: Lot: 6400048
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Midazolam: every company that makes it
- Form
- injection, solution, intramuscular; intravenous
- Strength
- 2 mg per 2 mL
- Approval
- ANDA ANDA203460
- On the market since
- Apr 16, 2021
- Package NDCs
76045-211-0076045-211-20- Official label
- DailyMed (National Library of Medicine), updated Jan 1, 2024
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?